Insiders AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Delayed Börse Stuttgart Other stock markets 08:03:53 05/10/2021 pm IST			5-day change	1st Jan Change
5.28 ^EUR	-0.19%		-10.02%	+20.93%

25/03	AVEO Pharmaceuticals, Inc. Announces Executive Changes	CI
06/02	Aveo Oncology Announces Publication of Long-Term Survival in Patients with Relapsed/Refractory Advanced Renal Cell Carcinoma Treated with Tivozanib: Analysis of the Phase Iii Tivo-3 Trial in the Oncologist	CI

Insiders

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

AVEO Pharmaceuticals, Inc. Announces Executive Changes	25/03	CI
AVEO Completes Acquisition by LG Chem	20/23/20	MT
AVEO Pharmaceuticals, Inc. Announces Management Changes	20/23/20	CI
AVEO Oncology Appoints Martin Birkhofer as Its Chief Medical Officer	20/23/20	CI
AVEO Pharmaceuticals Names Jeb Ledell as Operations Chief	01/21/01	MT
AVEO Oncology Appoints Jeb Ledell as Chief Operating Officer	01/21/01	CI
AVEO Pharmaceuticals, Inc. Announces Retirement of Michael Needle as Chief Medical Officer, with Effect from November 19, 2021	28/21/28	CI
AVEO Pharmaceuticals, Inc. Appoints Kevin Cullen to its Audit Committee and Compensation Committee	10/21/10	CI
AVEO Oncology Appoints Kevin J. Cullen to the Board of Directors	16/21/16	CI
AVEO Oncology Announces Appointment of Mike Ferraresso to Chief Commercial Officer	11/21/11	CI
AVEO Pharmaceuticals, Inc. Appoints Corinne Epperly as Member of the Board and to Its Nominating and Governance Committee and Compensation Committee	09/21/09	CI
AVEO Pharmaceuticals, Inc. Announces the Departure of Karuna Rubin, Senior Vice President and General Counsel	23/21/23	CI
AVEO Pharmaceuticals, Inc. Announces Management Changes	13/21/13	CI
AVEO Oncology Appoints David Crist as Vice President of Sales	22/20/22	CI
AVEO Oncology Announces Executive Appointments	06/20/06	CI
AVEO Announces Appointment of Erick J. Lucera as Chief Financial Officer	06/20/06	CI
Aveo Oncology Appoints Scarlett Spring to Its Board of Directors	19/19/19	CI
AVEO Oncology Announces Executive Changes	12/19/12	CI
Nikhil Mehta to Step Down as an Officer of AVEO Pharmaceuticals, Inc., Effective October 8, 2019	27/19/27	CI
AVEO Pharmaceuticals, Inc. Announces Executive Changes	28/19/28	CI

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Insiders AVEO Pharmaceuticals, Inc. Börse Stuttgart

Equities

VPA

US0535881090

Insiders

Filters